ZL-1503

DRUG2 trials

Sponsors

Zai Lab (Shanghai) Co., Ltd.

Conditions

Atopic Dermatitis (AD)Healthy Volunteers

Phase 1

A Phase 1/1b Study to Evaluate Safety, Tolerability and Pharmacokinetics of ZL-1503 in Healthy Volunteers and Participants With Moderate to Severe Atopic Dermatitis

RecruitingNCT07235384

Zai Lab (Shanghai) Co., Ltd.Atopic Dermatitis (AD)

Start: 2025-12-01End: 2027-12-28Target: 84Updated: 2026-08-07

A Phase 1 Study to Evaluate Pharmacokinetics, Safety and Tolerability of ZL-1503 in Healthy Volunteers

Not yet recruitingNCT07658482

Zai Lab (Shanghai) Co., Ltd.Healthy Volunteers

Start: 2026-09-03End: 2027-11-10Target: 36Updated: 2026-08-20